Alamar Biosciences, Inc. · NASDAQ:ALMR
Qiming Corporate GP VI, Ltd. sold 173,673 Alamar Biosciences, Inc. shares (Form 4)
Traded Oct 15 to Oct 16, 2026 · Filed Oct 19, 2026
From Oct 15 to Oct 16, 2026, Qiming Corporate GP VI, Ltd. (10% owner) sold 173,673 Alamar Biosciences, Inc. shares at an average US$27.73 for US$4.82M, leaving 1,890,817 shares. Filed Oct 19, 2026 (Form 4).
- Sold
- 173,673 shares
- Price
- US$27.73 average (US$27.02 to US$28.26)
- Value
- US$4.82M
- Holding after
- 1,890,817 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Sale | 3,024 | US$27.73 | 182,139 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 9 | US$28.26 | 182,130 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 112,392 | US$27.73 | 6,769,018 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 325 | US$28.26 | 6,768,693 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 26,224 | US$27.73 | 1,579,421 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 76 | US$28.26 | 1,579,345 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 31,397 | US$27.73 | 1,890,932 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 90 | US$28.26 | 1,890,842 | Indirect |
| Oct 16, 2026 | Common Stock | Sale | 2 | US$27.02 | 182,128 | Indirect |
| Oct 16, 2026 | Common Stock | Sale | 88 | US$27.02 | 6,768,605 | Indirect |
| Oct 16, 2026 | Common Stock | Sale | 21 | US$27.02 | 1,579,324 | Indirect |
| Oct 16, 2026 | Common Stock | Sale | 25 | US$27.02 | 1,890,817 | Indirect |
Source
Download original · View original at SEC
Related
- Alamar Biosciences, Inc.
- Qiming Corporate GP VI, Ltd.
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 21, 2026
- Form 4 · Brottem John L. · Sep 16, 2026
- Form 4 · Ragusa Robert P · Sep 3, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026
- Schedule 13D/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Jul 7, 2026